132, n o 2, 204210 (ISSN 0022-3166 et 1541-6100, DOI 10.1093/jn/132.2.204, lire en ligne, consult le
7 Conclusion and future development directions Collectively, patients with epilepsy exhibit elevated levels of glycolipids, inflammatory mediators, oxidative stressors, and apoptotic factors, while the pathogenic role of glucose metabolism disorders continues to garner significant attention
Studies with complete reporting and rigorous design were rated as "High," while others with some limitations or missing methodological details were rated as "Medium" or "Low." To evaluate the reliability and scientific rigor of the evidence presented in this review, we conducted a methodological quality assessment of the primary clinical trials included
The dual GLP-1/GIP receptor agonism mechanism addresses multiple hunger and metabolic pathways, explaining why tirzepatide often succeeds where single-pathway medications or diet-only approaches fail
xx Great post